Skip to content

AngioDynamics ANGO Current ratio

Current ratio at other companies

Abbott logo
AbbottABT
1.4×-0.4×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
0.9×-0.2×
TFX
TeleflexTFX
2.6×+0.3×
Stryker logo
StrykerSYK
2.1×+0.5×
Merit Medical Systems logo
Merit Medical SystemsMMSI
5.1×+0.2×
ICU Medical logo
ICU MedicalICUI
2.3×-0.3×

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0.0×

Where this comes from

Calculated from AngioDynamics’s reported figures.

Based on the most recent quarter.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's current ratio?
AngioDynamics (ANGO) reported current ratio of 2.4× in Q4 2025.
How has AngioDynamics's current ratio changed year-over-year?
AngioDynamics's current ratio increased by 6.6% year-over-year, from 2.2× to 2.4×.
What is the long-term trend for AngioDynamics's current ratio?
Over 4 years (2021 to 2025), AngioDynamics's current ratio has grown at a -2.5% compound annual growth rate (CAGR), from 2.4× to 2.2×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.